Cargando…
Primary pancreatic cystadenocarcinoma with ovarian metastases in a 38-year-old female: case report
Pancreatic cystadenocarcinoma with ovarian metastases is rare and easily misdiagnosed as primary ovarian cancers. Here we report 38-year-old female manifested tumors in pancreas and ovary concurrently, which was difficult to distinguish the primary site. She was admitted to hospital because of abdom...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798069/ https://www.ncbi.nlm.nih.gov/pubmed/35117364 http://dx.doi.org/10.21037/tcr-20-2361 |
_version_ | 1784641708257968128 |
---|---|
author | Wang, Shun-Da Dai, Meng-Hua Zhao, Yu-Pei |
author_facet | Wang, Shun-Da Dai, Meng-Hua Zhao, Yu-Pei |
author_sort | Wang, Shun-Da |
collection | PubMed |
description | Pancreatic cystadenocarcinoma with ovarian metastases is rare and easily misdiagnosed as primary ovarian cancers. Here we report 38-year-old female manifested tumors in pancreas and ovary concurrently, which was difficult to distinguish the primary site. She was admitted to hospital because of abdominal distension and a palpable mass in the lower abdomen. Abdominal ultrasound showed a lesion in pancreas and two masses in bilateral ovaries. Computed tomography (CT) revealed the hypo-enhancing pancreatic mass and the large pelvic lesion simultaneously. The largest cross-sectional of the right mass was 12×15.1 cm and 15.4×18.3 cm for the left side, probably malignant lesions. In addition, the level of the serum CA19-9 and CA125 were higher than the normal level. Positron emission tomography CT (PET-CT) revealed there might be the cystadenocarcinoma in the pancreatic tail with multiple metastatic lesions implanted in the pelvic. After comprehensive examination, she received bilateral salpingo-oophorectomy and biopsy of the pancreatic tumor. The pathological finding revealed that it was pancreatic cystadenocarcinoma with ovarian metastases. Postoperatively, she received the chemotherapy and the follow-up continued for 26 months until she died. This case reminded doctors that pancreatic primaries should be paid attention when dealing with metastatic ovarian malignancies although it was rare. Choosing effective diagnostic method and timely surgical intervention are essential to improve prognosis. |
format | Online Article Text |
id | pubmed-8798069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87980692022-02-02 Primary pancreatic cystadenocarcinoma with ovarian metastases in a 38-year-old female: case report Wang, Shun-Da Dai, Meng-Hua Zhao, Yu-Pei Transl Cancer Res Case Report Pancreatic cystadenocarcinoma with ovarian metastases is rare and easily misdiagnosed as primary ovarian cancers. Here we report 38-year-old female manifested tumors in pancreas and ovary concurrently, which was difficult to distinguish the primary site. She was admitted to hospital because of abdominal distension and a palpable mass in the lower abdomen. Abdominal ultrasound showed a lesion in pancreas and two masses in bilateral ovaries. Computed tomography (CT) revealed the hypo-enhancing pancreatic mass and the large pelvic lesion simultaneously. The largest cross-sectional of the right mass was 12×15.1 cm and 15.4×18.3 cm for the left side, probably malignant lesions. In addition, the level of the serum CA19-9 and CA125 were higher than the normal level. Positron emission tomography CT (PET-CT) revealed there might be the cystadenocarcinoma in the pancreatic tail with multiple metastatic lesions implanted in the pelvic. After comprehensive examination, she received bilateral salpingo-oophorectomy and biopsy of the pancreatic tumor. The pathological finding revealed that it was pancreatic cystadenocarcinoma with ovarian metastases. Postoperatively, she received the chemotherapy and the follow-up continued for 26 months until she died. This case reminded doctors that pancreatic primaries should be paid attention when dealing with metastatic ovarian malignancies although it was rare. Choosing effective diagnostic method and timely surgical intervention are essential to improve prognosis. AME Publishing Company 2020-12 /pmc/articles/PMC8798069/ /pubmed/35117364 http://dx.doi.org/10.21037/tcr-20-2361 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Case Report Wang, Shun-Da Dai, Meng-Hua Zhao, Yu-Pei Primary pancreatic cystadenocarcinoma with ovarian metastases in a 38-year-old female: case report |
title | Primary pancreatic cystadenocarcinoma with ovarian metastases in a 38-year-old female: case report |
title_full | Primary pancreatic cystadenocarcinoma with ovarian metastases in a 38-year-old female: case report |
title_fullStr | Primary pancreatic cystadenocarcinoma with ovarian metastases in a 38-year-old female: case report |
title_full_unstemmed | Primary pancreatic cystadenocarcinoma with ovarian metastases in a 38-year-old female: case report |
title_short | Primary pancreatic cystadenocarcinoma with ovarian metastases in a 38-year-old female: case report |
title_sort | primary pancreatic cystadenocarcinoma with ovarian metastases in a 38-year-old female: case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798069/ https://www.ncbi.nlm.nih.gov/pubmed/35117364 http://dx.doi.org/10.21037/tcr-20-2361 |
work_keys_str_mv | AT wangshunda primarypancreaticcystadenocarcinomawithovarianmetastasesina38yearoldfemalecasereport AT daimenghua primarypancreaticcystadenocarcinomawithovarianmetastasesina38yearoldfemalecasereport AT zhaoyupei primarypancreaticcystadenocarcinomawithovarianmetastasesina38yearoldfemalecasereport |